These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22222462)

  • 21. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
    World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.
    Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ
    Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans.
    Bae Y; Park C; Han J; Hong YJ; Song HH; Shin ES; Lee JE; Han BG; Jang Y; Shin DJ; Yoon SK
    J Hum Hypertens; 2007 Feb; 21(2):159-66. PubMed ID: 17066084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population.
    Eisenhardt A; Stief C; Porst H; Wetterauer U; Weidner W; Rübben H; Sperling H
    Andrologia; 2010 Aug; 42(4):218-24. PubMed ID: 20629643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Samonigg H
    Cancer Lett; 2004 Mar; 206(1):59-62. PubMed ID: 15019160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
    Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
    Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
    Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population.
    Ma J; Wang L; Yang Y; Qiao Z; Fang D; Qiu X; Yang X; Zhu X; He J; Pan H; Ban B; Zhao Y; Sui H
    PLoS One; 2017; 12(2):e0170994. PubMed ID: 28225778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation.
    Malaguti A; Rossini D; Lucca A; Magri L; Lorenzi C; Pirovano A; Colombo C; Smeraldi E; Zanardi R
    Depress Anxiety; 2011 Jul; 28(7):568-73. PubMed ID: 21449006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment.
    Bukh JD; Bock C; Vinberg M; Werge T; Gether U; Kessing LV
    Eur Neuropsychopharmacol; 2010 May; 20(5):327-35. PubMed ID: 20022223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders.
    Lee HJ; Cha JH; Ham BJ; Han CS; Kim YK; Lee SH; Ryu SH; Kang RH; Choi MJ; Lee MS
    Pharmacogenomics J; 2004; 4(1):29-33. PubMed ID: 14647404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3).
    de Vries DR; ter Linde JJ; van Herwaarden MA; Smout AJ; Samsom M
    Am J Gastroenterol; 2009 Feb; 104(2):281-5. PubMed ID: 19174793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension, obesity and GNB 3 gene variants.
    Danoviz ME; Pereira AC; Mill JG; Krieger JE
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):248-52. PubMed ID: 16487269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A protective effect of GLY272SER polymorphism of GNB3 gene in development of essential hypertension and its relations with environmental hypertension risk factors].
    Polonikov AV; Solodilova MA; Ivanov VP; Shestakov AM; Ushachev DV; Vialykh EK; Vasil'eva OV; Poliakova NV; Antsupov VV; Kabanina VA; Kupriianova IaS; Bulgakova IV; Kozhukhov MA; Tevs DS
    Ter Arkh; 2011; 83(4):55-60. PubMed ID: 21675276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.